市場調査レポート

商品コード

1302444

セルベースアッセイ市場：提供別、用途別、エンドユーザー別 - 2023～2030年の世界予測

Cell-based Assay Market by Offerings (Consumables, Instruments, Services), Application (Basic Research, Drug Discovery), End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 195 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 744,453円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 901,213円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,057,973円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,371,493円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のセルベースアッセイの市場規模は、2023年に166億3,000万米ドルとなり、CAGR7.42％で大きく成長し、2030年には275億米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のセルベースアッセイ市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発・イノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.セルベースアッセイの世界市場規模・予測は？

2.予測期間中、世界のセルベースアッセイ市場を形成するCOVID-19の阻害要因と影響は？

3.セルベースアッセイの世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.セルベースアッセイの世界市場における競争戦略は？

5.セルベースアッセイの世界市場における技術動向と規制の枠組みは？

6.セルベースアッセイの世界市場における主要ベンダーの市場シェアは？

7.セルベースアッセイの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 世界の心血管疾患、感染症、糖尿病、がんの有病率
  - 従来の治療法に対するセルベースアッセイの利点に関する認識
  - 新薬や治療法に対する世界の需要の高まり
- 抑制要因
  - 限られた熟練した専門家
- 機会
  - さまざまな超ハイスループットスクリーニングにおけるセルベースアッセイの使用の増加
  - セルベースアッセイに基づくインビトロの薬物研究数の増加
- 課題
  - 不利な規制の枠組み
市場動向
COVID-19の累積的影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章セルベースアッセイ市場：提供別

消耗品
- アッセイキット
- 細胞株
- マイクロプレート
- プローブとラベル
- 試薬
機器
サービス

第7章セルベースアッセイ市場：用途別

基礎研究
創薬
- 薬力学研究
- 薬物動態研究
- 毒性研究

第8章セルベースアッセイ市場：エンドユーザー別

学術機関・政府機関
受託研究機関
製薬・バイオテクノロジー企業

第9章南北アメリカのセルベースアッセイ市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第10章アジア太平洋地域のセルベースアッセイ市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第11章欧州・中東・アフリカのセルベースアッセイ市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第12章競合情勢

FPNVポジショニングマトリックス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第13章掲載企業一覧

第14章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. CELL-BASED ASSAY MARKET RESEARCH PROCESS
FIGURE 2. CELL-BASED ASSAY MARKET SIZE, 2022 VS 2030
FIGURE 3. CELL-BASED ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2022 VS 2030 (%)
FIGURE 5. CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 6. CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 7. CELL-BASED ASSAY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 8. CELL-BASED ASSAY MARKET DYNAMICS
FIGURE 9. CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 10. CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. CELL-BASED ASSAY MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 17. CELL-BASED ASSAY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. CELL-BASED ASSAY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. CELL-BASED ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 5. CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 6. CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CELL-BASED ASSAY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CELL-BASED ASSAY MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CELL-BASED ASSAY MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CELL-BASED ASSAY MARKET SIZE, BY PROBES & LABELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CELL-BASED ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CELL-BASED ASSAY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CELL-BASED ASSAY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 15. CELL-BASED ASSAY MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 17. CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CELL-BASED ASSAY MARKET SIZE, BY PHARMACODYNAMIC STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CELL-BASED ASSAY MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. CELL-BASED ASSAY MARKET SIZE, BY TOXICITY STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. CELL-BASED ASSAY MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. CELL-BASED ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. CELL-BASED ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. CANADA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 42. CANADA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 43. CANADA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. CANADA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 45. CANADA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. MEXICO CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 47. MEXICO CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 48. MEXICO CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. MEXICO CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 50. MEXICO CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. CHINA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 69. CHINA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 70. CHINA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. CHINA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 72. CHINA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. INDIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 74. INDIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 75. INDIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. INDIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 77. INDIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. JAPAN CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 84. JAPAN CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 85. JAPAN CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. JAPAN CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 87. JAPAN CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. THAILAND CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 114. THAILAND CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 115. THAILAND CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. THAILAND CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 117. THAILAND CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. DENMARK CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 130. DENMARK CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 131. DENMARK CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. DENMARK CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 133. DENMARK CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. EGYPT CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 135. EGYPT CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 136. EGYPT CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. EGYPT CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 138. EGYPT CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. FINLAND CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 140. FINLAND CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 141. FINLAND CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. FINLAND CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 143. FINLAND CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. FRANCE CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 145. FRANCE CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 146. FRANCE CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. FRANCE CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 148. FRANCE CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. GERMANY CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 150. GERMANY CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 151. GERMANY CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. GERMANY CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 153. GERMANY CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. ITALY CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 160. ITALY CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 161. ITALY CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. ITALY CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 163. ITALY CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. NORWAY CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 175. NORWAY CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 176. NORWAY CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. NORWAY CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 178. NORWAY CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. POLAND CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 180. POLAND CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 181. POLAND CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. POLAND CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 183. POLAND CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. QATAR CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 185. QATAR CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 186. QATAR CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. QATAR CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 188. QATAR CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. SPAIN CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 205. SPAIN CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 206. SPAIN CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. SPAIN CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 208. SPAIN CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. TURKEY CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 220. TURKEY CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 221. TURKEY CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. TURKEY CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 223. TURKEY CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. CELL-BASED ASSAY MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 235. CELL-BASED ASSAY MARKET SHARE, BY KEY PLAYER, 2022
TABLE 236. CELL-BASED ASSAY MARKET LICENSE & PRICING

Product Code: MRR-436B79517C47

The Global Cell-based Assay Market is forecasted to grow significantly, with a projected USD 16.63 billion in 2023 at a CAGR of 7.42% and expected to reach a staggering USD 27.50 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cell-based Assay Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cell-based Assay Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Offerings, market is studied across Consumables, Instruments, and Services. The Consumables is further studied across Assay Kits, Cell Lines, Microplates, Probes & Labels, and Reagents. The Instruments is projected to witness significant market share during forecast period.

Based on Application, market is studied across Basic Research and Drug Discovery. The Drug Discovery is further studied across Pharmacodynamic Studies, Pharmacokinetic Studies, and Toxicity Studies. The Drug Discovery is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic & Government Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies. The Academic & Government Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cell-based Assay Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cell-based Assay Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell-based Assay Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell-based Assay Market?

4. What is the competitive strategic window for opportunities in the Global Cell-based Assay Market?

5. What are the technology trends and regulatory frameworks in the Global Cell-based Assay Market?

6. What is the market share of the leading vendors in the Global Cell-based Assay Market?

7. What modes and strategic moves are considered suitable for entering the Global Cell-based Assay Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Cell-based Assay Market, by Offerings, 2022 vs 2030
4.3. Cell-based Assay Market, by Application, 2022 vs 2030
4.4. Cell-based Assay Market, by End-User, 2022 vs 2030
4.5. Cell-based Assay Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Prevalence of cardiovascular & infectious disease, diabetes, and cancer worldwide
  - 5.1.1.2. Awareness regarding advantages of cell-based assays over traditional treatments
  - 5.1.1.3. Rising worldwide demand for novel drugs and treatments
- 5.1.2. Restraints
  - 5.1.2.1. Limited skilled professionals
- 5.1.3. Opportunities
  - 5.1.3.1. Rising use of cell-based assays in various ultra-high throughput screening
  - 5.1.3.2. Growing number of in-vitro drug studies based on cell-based assays
- 5.1.4. Challenges
  - 5.1.4.1. Unfavorable regulatory framework
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Cell-based Assay Market, by Offerings

6.1. Introduction
6.2. Consumables
- 6.2.1. Assay Kits
- 6.2.2. Cell Lines
- 6.2.3. Microplates
- 6.2.4. Probes & Labels
- 6.2.5. Reagents
6.3. Instruments
6.4. Services

7. Cell-based Assay Market, by Application

7.1. Introduction
7.2. Basic Research
7.3. Drug Discovery
- 7.3.1. Pharmacodynamic Studies
- 7.3.2. Pharmacokinetic Studies
- 7.3.3. Toxicity Studies

8. Cell-based Assay Market, by End-User

8.1. Introduction
8.2. Academic & Government Institutes
8.3. Contract Research Organizations
8.4. Pharmaceutical & Biotechnology Companies

9. Americas Cell-based Assay Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Cell-based Assay Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Cell-based Assay Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

セルベースアッセイ市場：提供別、用途別、エンドユーザー別 - 2023～2030年の世界予測

Cell-based Assay Market by Offerings (Consumables, Instruments, Services), Application (Basic Research, Drug Discovery), End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 セルベースアッセイ市場：提供別

第7章 セルベースアッセイ市場：用途別

第8章 セルベースアッセイ市場：エンドユーザー別

第9章 南北アメリカのセルベースアッセイ市場

第10章 アジア太平洋地域のセルベースアッセイ市場

第11章 欧州・中東・アフリカのセルベースアッセイ市場

第12章 競合情勢

第13章 掲載企業一覧

第14章 付録